EE200100432A - DNA molekul, seda sisaldav vektor ning DNA molekuli, rekombinantsete peremeesrakkude ja glükoproteiinide valmistamismeetod - Google Patents
DNA molekul, seda sisaldav vektor ning DNA molekuli, rekombinantsete peremeesrakkude ja glükoproteiinide valmistamismeetodInfo
- Publication number
- EE200100432A EE200100432A EEP200100432A EEP200100432A EE200100432A EE 200100432 A EE200100432 A EE 200100432A EE P200100432 A EEP200100432 A EE P200100432A EE P200100432 A EEP200100432 A EE P200100432A EE 200100432 A EE200100432 A EE 200100432A
- Authority
- EE
- Estonia
- Prior art keywords
- sequence
- dna molecule
- alpha
- glcnac
- plant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- Pulmonology (AREA)
- Cell Biology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0027099A AT408446B (de) | 1999-02-18 | 1999-02-18 | Fucosyltransferase-gen |
PCT/AT2000/000040 WO2000049153A1 (de) | 1999-02-18 | 2000-02-17 | Fucosyltransferase-gen |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200100432A true EE200100432A (et) | 2002-12-16 |
Family
ID=3486087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200100432A EE200100432A (et) | 1999-02-18 | 2000-02-17 | DNA molekul, seda sisaldav vektor ning DNA molekuli, rekombinantsete peremeesrakkude ja glükoproteiinide valmistamismeetod |
Country Status (29)
Country | Link |
---|---|
US (3) | US8198078B2 (is) |
EP (3) | EP2062977B1 (is) |
JP (2) | JP5514386B2 (is) |
KR (1) | KR20010108234A (is) |
CN (1) | CN1360633A (is) |
AT (2) | AT408446B (is) |
AU (1) | AU771995B2 (is) |
BG (1) | BG65140B1 (is) |
BR (1) | BR0010114A (is) |
CA (1) | CA2362964C (is) |
CZ (2) | CZ308081B6 (is) |
DE (1) | DE50011116D1 (is) |
DK (2) | DK1151109T3 (is) |
EE (1) | EE200100432A (is) |
ES (2) | ES2246222T3 (is) |
HR (1) | HRP20010681A2 (is) |
HU (1) | HU230075B1 (is) |
IL (2) | IL144777A0 (is) |
IS (1) | IS6041A (is) |
MX (1) | MXPA01008372A (is) |
NO (1) | NO20013993L (is) |
NZ (1) | NZ513685A (is) |
PL (2) | PL205785B1 (is) |
PT (1) | PT2062977E (is) |
SK (1) | SK286416B6 (is) |
TR (1) | TR200102393T2 (is) |
WO (1) | WO2000049153A1 (is) |
YU (1) | YU58901A (is) |
ZA (1) | ZA200106735B (is) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2354377C (en) | 1998-12-09 | 2007-04-10 | Tatsuji Seki | A method for manufacturing glycoproteins having human-type glycosylation |
AT408446B (de) * | 1999-02-18 | 2001-11-26 | Altmann Friedrich Dr | Fucosyltransferase-gen |
DK2270150T4 (da) | 1999-04-09 | 2019-08-26 | Kyowa Hakko Kirin Co Ltd | Fremgangsmåde til at kontrollere aktiviteten af immunologisk funktionelt molekyle. |
DE60035285T2 (de) | 1999-10-26 | 2008-02-21 | Plant Research International B.V. | Glykolisierung des säugetiertyps in pflanzen |
US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
IL156879A0 (en) | 2001-01-19 | 2004-02-08 | Dow Chemical Co | Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
CA2923247A1 (en) | 2002-03-19 | 2003-09-25 | Stichting Dienst Landbouwkundig Onderzoek | Optimizing glycan processing in plants |
EP1485492B1 (en) | 2002-03-19 | 2011-12-21 | Stichting Dienst Landbouwkundig Onderzoek | Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta(1,4)-n-acetylglucosaminyltransferase iii) expression in plants |
ES2362419T3 (es) | 2002-04-09 | 2011-07-05 | Kyowa Hakko Kirin Co., Ltd. | Células con depresión o deleción de la actividad de la proteína que participa en el transporte de gdp-fucosa. |
CL2003002461A1 (es) | 2002-11-27 | 2005-01-07 | Dow Chemical Company Agroscien | Inmunoglobulina que comprende al menos un glicano afucosilado, composicion que la contiene, secuencia nucleotidica y vector que la comprende, procedimiento para producir dicha inmunoglobulina en plantas. |
EP1510584B1 (en) | 2003-08-11 | 2009-03-18 | Greenovation Biotech GmbH | Expression promoting sequences from mosses and their uses |
FI20055398A0 (fi) | 2005-07-08 | 2005-07-08 | Suomen Punainen Risti Veripalv | Menetelmä solupopulaatioiden evaluoimiseksi |
KR20080094918A (ko) | 2006-01-17 | 2008-10-27 | 바이오렉스 쎄라퓨틱스, 인코포레이티드 | 식물에서 n-글리칸의 인간화 및 최적화 조성물 및 방법 |
US20090060921A1 (en) * | 2006-01-17 | 2009-03-05 | Biolex Therapeutics, Inc. | Glycan-optimized anti-cd20 antibodies |
CN102094019B (zh) * | 2007-01-15 | 2012-11-28 | 燕秋 | 用于抑制LeY糖抗原合成的岩藻糖基转移酶Ⅳ的RNA干涉序列及重组干涉质粒 |
CN102094020B (zh) * | 2007-01-15 | 2012-11-28 | 燕秋 | 用于抑制LeY糖抗原合成的岩藻糖基转移酶I的RNA干涉序列及重组干涉质粒 |
NZ580510A (en) | 2007-04-17 | 2011-06-30 | Stichting Dienst Landbouwkundi | Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases |
US7871785B2 (en) * | 2007-09-07 | 2011-01-18 | Children's Hospital Medical Center | Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease |
WO2009056155A1 (en) * | 2007-10-31 | 2009-05-07 | Bayer Bioscience N.V. | Method to produce modified plants with altered n-glycosylation pattern |
EP2166085A1 (en) | 2008-07-16 | 2010-03-24 | Suomen Punainen Risti Veripalvelu | Divalent modified cells |
DK2439264T3 (en) * | 2010-10-11 | 2015-08-03 | Jennewein Biotechnologie Gmbh | Novel fucosyltransferases and their use |
KR101293658B1 (ko) * | 2010-12-30 | 2013-08-07 | 대한민국 | 알파-1,3-푸코실트랜스퍼라아제 및/또는 베타-1,2-자일로실트렌스퍼라아제 유전자를 포함하는 벼 형질전환용 벡터 및 형질전환된 벼 |
EP2479263B1 (en) * | 2011-01-20 | 2013-11-27 | Jennewein Biotechnologie GmbH | Novel Fucosyltransferases and their applications |
EP2789686A1 (en) | 2013-04-11 | 2014-10-15 | Greenovation Biotech GmbH | Expression of phosphorylated glycoproteins in plants |
EP3050973A1 (en) * | 2015-01-30 | 2016-08-03 | Jennewein Biotechnologie GmbH | Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars |
CN110317799A (zh) * | 2019-07-18 | 2019-10-11 | 江南大学 | 一种人源岩藻糖转移酶8的原核表达方法及其产品 |
EP3871687A1 (en) | 2020-02-27 | 2021-09-01 | eleva GmbH | Enzyme replacement therapy for treating pompe disease |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5272066A (en) | 1986-03-07 | 1993-12-21 | Massachusetts Institute Of Technology | Synthetic method for enhancing glycoprotein stability |
JP3756946B2 (ja) | 1993-03-29 | 2006-03-22 | 協和醗酵工業株式会社 | α1,3−フコシルトランスフェラーゼ |
US6509149B2 (en) * | 1995-06-06 | 2003-01-21 | Hybridon, Inc. | HPV-specific oligonucleotides |
US5770420A (en) * | 1995-09-08 | 1998-06-23 | The Regents Of The University Of Michigan | Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures |
AT408446B (de) * | 1999-02-18 | 2001-11-26 | Altmann Friedrich Dr | Fucosyltransferase-gen |
-
1999
- 1999-02-18 AT AT0027099A patent/AT408446B/de not_active IP Right Cessation
-
2000
- 2000-02-17 DK DK00904677T patent/DK1151109T3/da active
- 2000-02-17 YU YU58901A patent/YU58901A/sh unknown
- 2000-02-17 MX MXPA01008372A patent/MXPA01008372A/es active IP Right Grant
- 2000-02-17 TR TR2001/02393T patent/TR200102393T2/xx unknown
- 2000-02-17 ES ES00904677T patent/ES2246222T3/es not_active Expired - Lifetime
- 2000-02-17 AT AT00904677T patent/ATE304053T1/de active
- 2000-02-17 DE DE50011116T patent/DE50011116D1/de not_active Expired - Lifetime
- 2000-02-17 EP EP09154489.0A patent/EP2062977B1/de not_active Expired - Lifetime
- 2000-02-17 JP JP2000599878A patent/JP5514386B2/ja not_active Expired - Lifetime
- 2000-02-17 CZ CZ2008-404A patent/CZ308081B6/cs not_active IP Right Cessation
- 2000-02-17 EP EP05108012A patent/EP1642979A1/de not_active Withdrawn
- 2000-02-17 HU HU0200394A patent/HU230075B1/hu unknown
- 2000-02-17 CN CN00805192A patent/CN1360633A/zh active Pending
- 2000-02-17 SK SK1118-2001A patent/SK286416B6/sk not_active IP Right Cessation
- 2000-02-17 IL IL14477700A patent/IL144777A0/xx active IP Right Grant
- 2000-02-17 KR KR1020017010518A patent/KR20010108234A/ko not_active Application Discontinuation
- 2000-02-17 CA CA2362964A patent/CA2362964C/en not_active Expired - Lifetime
- 2000-02-17 ES ES09154489.0T patent/ES2444126T3/es not_active Expired - Lifetime
- 2000-02-17 NZ NZ513685A patent/NZ513685A/en unknown
- 2000-02-17 BR BR0010114-1A patent/BR0010114A/pt not_active Application Discontinuation
- 2000-02-17 PL PL363438A patent/PL205785B1/pl unknown
- 2000-02-17 EE EEP200100432A patent/EE200100432A/xx unknown
- 2000-02-17 PL PL385768A patent/PL205710B1/pl unknown
- 2000-02-17 WO PCT/AT2000/000040 patent/WO2000049153A1/de active IP Right Grant
- 2000-02-17 EP EP00904677A patent/EP1151109B1/de not_active Expired - Lifetime
- 2000-02-17 DK DK09154489.0T patent/DK2062977T3/da active
- 2000-02-17 CZ CZ20012943A patent/CZ299622B6/cs not_active IP Right Cessation
- 2000-02-17 PT PT91544890T patent/PT2062977E/pt unknown
- 2000-02-17 AU AU26460/00A patent/AU771995B2/en not_active Expired
-
2001
- 2001-08-07 IL IL144777A patent/IL144777A/en not_active IP Right Cessation
- 2001-08-08 IS IS6041A patent/IS6041A/is unknown
- 2001-08-15 ZA ZA200106735A patent/ZA200106735B/en unknown
- 2001-08-16 NO NO20013993A patent/NO20013993L/no unknown
- 2001-09-13 BG BG105899A patent/BG65140B1/bg unknown
- 2001-09-17 HR HR20010681A patent/HRP20010681A2/hr not_active Application Discontinuation
-
2007
- 2007-06-06 US US11/808,097 patent/US8198078B2/en not_active Expired - Fee Related
- 2007-06-06 US US11/808,096 patent/US20080234471A1/en not_active Abandoned
-
2011
- 2011-01-04 JP JP2011000049A patent/JP2011120592A/ja active Pending
-
2012
- 2012-05-15 US US13/471,759 patent/US8895806B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200100432A (et) | DNA molekul, seda sisaldav vektor ning DNA molekuli, rekombinantsete peremeesrakkude ja glükoproteiinide valmistamismeetod | |
KR100365969B1 (ko) | 퀴놀레이트 포스포리보실 트랜스퍼라제 발현의 조절 | |
Heintzen et al. | A light‐and temperature‐entrained circadian clock controls expression of transcripts encoding nuclear proteins with homology to RNA‐binding proteins in meristematic tissue | |
JP2002536978A5 (is) | ||
CA2272844A1 (en) | Novel nucleic acid molecules from maize and their use for the production of modified starch | |
CA2348366A1 (en) | Nucleic acid molecules from rice and their use for the production of modified starch | |
PL347223A1 (en) | Nucleic acid molecules which code a branching enzyme from bacteria of the genus neisseria, and a method for producing α-1,6-branched α-1,4-glucans | |
Rosche et al. | Genomic structure and expression of the pyruvate, orthophosphate dikinase gene of the dicotyledonous C 4 plant Flaveria trinervia (Asteraceae) | |
JPH06502759A (ja) | 組換えaccシンターゼ | |
Jones et al. | Novel ubiquitin-like ribosomal protein fusion genes from the nematodes Caenorhabditis elegans and Caenorhabditis briggsae. | |
Visioli et al. | Differential display-mediated isolation of a genomic sequence for a putative mitochondrial LMW HSP specifically expressed in condition of induced thermotolerance in Arabidopsis thaliana (L.) Heynh. | |
CN109468334A (zh) | 一种烟草蛋白激酶基因NtCIPK25-1及其克隆方法与应用 | |
CN109337918A (zh) | 一种烟草蛋白激酶基因NtCIPK1及其克隆方法与应用 | |
CN109468329A (zh) | 一种烟草外向整流钾离子通道基因NtSKOR1及其克隆方法与应用 | |
KR960702865A (ko) | 퓨트레신 n-메틸트랜스퍼라제와, 이를 코딩하는 재조합 dna 분자 및 알칼로이드 함량이 감소된 유전자 변이된 담배 식물(putrescine n-methyltransfera-se, recombinant dna molecules encoding putrescine n-methyltranferase, and transgenic tobacco plants with decreased alkaloid content) | |
CN110004173B (zh) | 一种获得非转基因耐储存鲜食枸杞的方法 | |
BR112012028860A2 (pt) | cepas spnk. | |
Matsuda et al. | Tissue‐specific isoforms of the bovine mitochondrial ATP synthase γ‐subunit | |
US7700358B2 (en) | Coffee mannanase | |
JP2003116384A (ja) | フェノールオキシダーゼ遺伝子を導入した植物、及び該植物によるフェノールオキシダーゼの生産方法 | |
RU2001125498A (ru) | Ген фукозилтрансферазы | |
JPH06153966A (ja) | 新規なタンパク質およびそれをコードする遺伝子 | |
CN118389580A (zh) | Abh基因在调控植物盐胁迫抗性中的用途 | |
CN116063425A (zh) | TaGS蛋白质或生物材料在调控植物耐盐碱性、或植物育种中的应用 | |
CN117904136A (zh) | 一种培育富含黄酮醇烟草的方法及其应用 |